High Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy
Learn more about:
Related Clinical Trial
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients
An Observational Study to Assess Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy
Differential Study of Muscle Transcriptome
Study of Hepatic Function in Patients With Spinal and Bulbar Muscular Atrophy
High Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy
Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg “All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)”
Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)